Grace Therapeutics, Inc. · NASDAQ:GRCE

Grace Therapeutics, Inc. insider trades

Grace Therapeutics, Inc.'s insiders made 19 buys and 0 sales on the open market in the last 12 months. Each trade with the insider, role, price and filing.

DateInsiderTradeSharesPriceFiling
Oct 19, 2026Opaleye Management Inc.Buy4,256US$2Form 4
Oct 16, 2026Opaleye Management Inc.Buy36,347US$2Form 4
Oct 15, 2026Opaleye Management Inc.Buy23,485US$2Form 4
Oct 14, 2026Opaleye Management Inc.Buy11,233US$2Form 4
Oct 12, 2026Opaleye Management Inc.Buy7,215US$2Form 4
Oct 9, 2026Opaleye Management Inc.Buy5,340US$2Form 4
Oct 8, 2026Opaleye Management Inc.Buy2,077US$2Form 4
Oct 5, 2026Opaleye Management Inc.Buy1,694US$2Form 4
Oct 2, 2026Opaleye Management Inc.Buy20,000US$2Form 4
Oct 1, 2026Opaleye Management Inc.Buy38,796US$2Form 4

Grace Therapeutics, Inc. shareholders